ArriVent BioPharma, Inc. - 8-K Filing
ArriVent BioPharma held its annual stockholder meeting on June 18, 2026, where James Healy, John Hohneker, and Stuart Lutzker were elected to the board of directors. Stockholders also ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal year ending December 31, 2026. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $AVBP